American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

Simple item page
dc.contributor.authorCuker, Adam
dc.contributor.authorTseng, Eric K.
dc.contributor.authorNieuwlaat, Robby
dc.contributor.authorAngchaisuksiri, Pantep
dc.contributor.authorBlair, Clifton
dc.contributor.authorDane, Kathryn
dc.contributor.authorDavila, Jennifer
dc.contributor.authorDeSancho, Maria T.
dc.contributor.authorDiuguid, David
dc.contributor.authorGriffin, Daniel O.
dc.contributor.authorKahn, Susan R.
dc.contributor.authorKlok, Frederikus A.
dc.contributor.authorLee, Alfred Ian
dc.contributor.authorNeumann, Ignacio
dc.contributor.authorPai, Ashok
dc.contributor.authorRighini, Marc
dc.contributor.authorSanfilippo, Kristen M.
dc.contributor.authorSiegal, Deborah
dc.contributor.authorSkara, Mike
dc.contributor.authorTerrell, Deirdra R.
dc.contributor.authorTouri, Kamshad
dc.contributor.authorAkl, Elie A.
dc.contributor.authorAl Jabiri, Reyad Nayif
dc.contributor.authorAl Jabiri, Yazan Nayif
dc.contributor.authorBarbara, Angela M.
dc.contributor.authorBognanni, Antonio
dc.contributor.authorAkl, Imad Bou
dc.contributor.authorBoulos, Mary
dc.contributor.authorBrignardello-Petersen, Romina
dc.contributor.authorCharide, Rana
dc.contributor.authorChan, Matthew
dc.contributor.authorColunga-Lozano, Luis E.
dc.contributor.authorDearness, Karin
dc.contributor.authorDarzi, Andrea J.
dc.contributor.authorHussein, Heba
dc.contributor.authorKaram, Samer G.
dc.contributor.authorKolb, Philipp
dc.contributor.authorMansour, Razan
dc.contributor.authorMorgano, Gian Paolo
dc.contributor.authorMorsi, Rami Z.
dc.contributor.authorMuti-Schunemann, Giovanna
dc.contributor.authorNadim, Menatalla K.
dc.contributor.authorNoori, Atefeh
dc.contributor.authorPhilip, Binu A.
dc.contributor.authorPiggott, Thomas
dc.contributor.authorQiu, Yuan
dc.contributor.authorBenitez, Yetiani Roldan
dc.contributor.authorSchunemann, Finn
dc.contributor.authorStevens, Adrienne
dc.contributor.authorSolo, Karla
dc.contributor.authorWiercioch, Wojtek
dc.contributor.authorMustafa, Reem A.
dc.contributor.authorSchunemann, Holger J.
dc.date.accessioned2025-01-20T21:13:16Z
dc.date.available2025-01-20T21:13:16Z
dc.date.issued2022
dc.description.abstractBackground: COVID-19-related acute illness is associated with an increased risk of venous thromboembolism (VTE).
dc.description.abstractObjective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in decisions about the use of anticoagulation for thromboprophylaxis in patients with COVID-19 who do not have confirmed or suspected VTE.
dc.description.abstractMethods: ASH formed a multidisciplinary guideline panel, including 3 patient representatives, and applied strategies to minimize potential bias from conflicts of interest. The McMaster University GRADE Centre supported the guideline development process, including performing systematic evidence reviews (up to March 2021). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the grading of recommendations assessment, development, and evaluation (GRADE) approach to assess evidence and make recommendations, which were subject to public comment.
dc.description.abstractResults: The panel agreed on 1 additional recommendation. The panel issued a conditional recommendation against the use of outpatient anticoagulant prophylaxis in patients with COVID-19 who are discharged from the hospital and who do not have suspected or confirmed VTE or another indication for anticoagulation.
dc.description.abstractConclsions: This recommendation was based on very low certainty in the evidence, underscoring the need for high-quality randomized controlled trials assessing the role of postdischarge thromboprophylaxis. Other key research priorities include better evidence on assessing risk of thrombosis and bleeding outcomes in patients with COVID-19 after hospital discharge.
dc.fuente.origenWOS
dc.identifier.doi10.1182/bloodadvances.2021005945
dc.identifier.eissn2473-9537
dc.identifier.issn2473-9529
dc.identifier.urihttps://doi.org/10.1182/bloodadvances.2021005945
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/93697
dc.identifier.wosidWOS:000754639300010
dc.issue.numero2
dc.language.isoen
dc.pagina.final671
dc.pagina.inicio664
dc.revistaBlood advances
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleAmerican Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis
dc.typeartículo
dc.volumen6
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas